Jörg Striessnig

Dr. Jörg Striessnig

orcid

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2005 in Pharmacological Reviews
Verified
Journal Article
Closed access
PDF file
WCWilliam A. Catterall
William A. Catterall
EPEdward Perez-Reyes
Edward Perez-Reyes
TSTerrance P. Snutch
Terrance P. Snutch
JSJörg Striessnig
Jörg Striessnig
The family of voltage-gated calcium channels serves as the key transducers of cell surface membrane potential changes into local intracellular calcium transients that initiate many different physiological events. There are 10 members of the voltage-gated calcium channel family that have been characterized in mammals, and they serve distinct roles in cellular signal transduction. This article presents the molecular relationships and physiological functions of these calcium channel proteins and provides comprehensive information on their molecular, genetic, physiological, and pharmacological properties.

1 July 2000 in Cell
Verified
Journal Article
Closed access
JPJosef Platzer
Josef Platzer
JEJutta Engel
Jutta Engel
ASanneliese schrott-fischer
anneliese schrott-fischer
KSKurt Stephan
Kurt Stephan
SBSergio Bova
Sergio Bova
JSJörg Striessnig
Jörg Striessnig

23 July 1996 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MHM Hanner
M Hanner
FMF F Moebius
F F Moebius
AFA Flandorfer
A Flandorfer
HKH G Knaus
H G Knaus
JSJörg Striessnig
Jörg Striessnig
HGHartmut Glossmann
Hartmut Glossmann
Sigma-ligands comprise several chemically unrelated drugs such as haloperidol, pentazocine, and ditolylguanidine, which bind to a family of low molecular mass proteins in the endoplasmic reticulum. These so-called sigma-receptors are believed to mediate various pharmacological effects of sigma-ligands by as yet unknown mechanisms. Based on their opposite enantioselectivity for benzomorphans and different molecular masses, two subtypes are differentiated. We purified the sigma1-binding site as a single 30-kDa protein from guinea pig liver employing the benzomorphan(+)[3H]pentazocine and the arylazide (-)[3H]azidopamil as specific probes. The purified (+)[3H]pentazocine-binding protein retained its high affinity for haloperidol, pentazocine, and ditolylguanidine. Partial amino acid sequence obtained after trypsinolysis revealed no homology to known proteins. Radiation inactivation of the pentazocine-labeled sigma1-binding site yielded a molecular mass of 24 +/- 2 kDa. The corresponding cDNA was cloned using degenerate oligonucleotides and cDNA library screening. Its open reading frame encoded a 25.3-kDa protein with at least one putative transmembrane segment. The protein expressed in yeast cells transformed with the cDNA showed the pharmacological characteristics of the brain and liver sigma1-binding site. The deduced amino acid sequence was structurally unrelated to known mammalian proteins but it shared homology with fungal proteins involved in sterol synthesis. Northern blots showed high densities of the sigma1-binding site mRNA in sterol-producing tissues. This is also in agreement with the known ability of sigma1-binding sites to interact with steroids, such as progesterone.

4 August 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EAElena A B Azizan
Elena A B Azizan
HPHanne Poulsen
Hanne Poulsen
PTPetronel Tuluc
Petronel Tuluc
JZJunhua Zhou
Junhua Zhou
MCMichael V Clausen
Michael V Clausen
MBMorris J Brown
Morris J Brown

1 May 2003 in Nature Reviews Neuroscience
Verified
Journal Article
Closed access
DPDaniela Pietrobon
Daniela Pietrobon
JSJörg Striessnig
Jörg Striessnig

16 April 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MMMatteo Elia Mangoni
Matteo Elia Mangoni
BCBrigitte Couette
Brigitte Couette
EBEmmanuel Bourinet
Emmanuel Bourinet
JPJosef Platzer
Josef Platzer
DRDaniel Reimer
Daniel Reimer
JNJoël Nargeot
Joël Nargeot
The spontaneous activity of pacemaker cells in the sino-atrial node (SAN) controls the heart rhythm and rate under physiological conditions. Pacemaker activity in SAN cells is due to the presence of the diastolic depolarization, a slow depolarization phase that drives the membrane voltage from the end of an action potential to the threshold of a new action potential. SAN cells express a wide array of ionic channels, but we have limited knowledge about their functional role in pacemaker activity and we still do not know which channels play a prominent role in the generation of the diastolic depolarization. It is thus important to provide genetic evidence linking the activity of genes coding for ionic channels to specific alterations of pacemaker activity of SAN cells. Here, we show that target inactivation of the gene coding for α 1D (Ca v 1.3) Ca 2+ channels in the mouse not only significantly slows pacemaker activity but also promotes spontaneous arrhythmia in SAN pacemaker cells. These alterations of pacemaker activity are linked to abolition of the major component of the L-type current ( I Ca,L ) activating at negative voltages. Pharmacological analysis of I Ca,L demonstrates that Ca v 1.3 gene inactivation specifically abolishes I Ca,L in the voltage range corresponding to the diastolic depolarization. Taken together, our data demonstrate that Ca v 1.3 channels play a major role in the generation of cardiac pacemaker activity by contributing to diastolic depolarization in SAN pacemaker cells.